Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 866 across all filing types
Latest filing 2026-05-06 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2026
Regulatory Filings
2026-05-06 English
Annual Report 2025
Regulatory Filings
2026-04-29 English
(revised) Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2026
Share Issue/Capital Change Classification · 80% confidence The document is a mandatory monthly return (Form FF301) filed to the Hong Kong Stock Exchange detailing movements in the issuer’s authorised/registered share capital, issued shares, treasury shares, and public float sufficiency under Chapter 19B of the Listing Rules. It focuses entirely on share capital changes and share movements (conversion of unlisted shares into H shares), satisfying the definition of a capital change announcement. Thus, the most appropriate classification is Share Issue/Capital Change (SHA).
2026-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2026
Regulatory Filings Classification · 91% confidence The document is a monthly regulatory return (Form FF301) filed with the Hong Kong Stock Exchange reporting movements in authorised share capital, issued shares, and public float sufficiency under Exchange Listing Rules. It is not an earnings release, annual or interim report, nor an investor presentation, but a routine filing under exchange rules. No specific bespoke category exists for monthly share movement returns, so it falls into the general Regulatory Filings category.
2026-04-02 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025; AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025'. It contains comprehensive consolidated financial statements, including the statement of profit or loss, statement of financial position, and detailed notes to the financial statements. While it is an 'announcement' format common in Hong Kong Stock Exchange filings, it provides the full substantive financial data and analysis for the fiscal year, which qualifies it as an Annual Report (10-K equivalent in this context). FY 2025
2026-03-30 English
VOLUNTARY ANNOUNCEMENT - RESEARCH RESULTS FOR FIVE INNOVATIVE DRUG PROJECTS WILL BE PRESENTED AT 2026 AACR ANNUAL MEETING
Regulatory Filings Classification · 85% confidence The document is a voluntary announcement on the Hong Kong Stock Exchange about the Company’s upcoming presentation of research results at an industry conference. It does not disclose financial results, management changes, capital actions, or regulatory/legal proceedings, nor is it an AGM, earnings release, or prospectus. It is a general corporate update that does not fit any highly specific category, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-03-25 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.